Adrenal Glands and Environmental Chemical Sensitivity
The adrenal glands regulate cortisol production in response to stress, immune challenges, and metabolic demands. PFAS compounds accumulate in adrenal tissue and disrupt the hypothalamic-pituitary-adrenal (HPA) axis at multiple regulatory levels.
Cortisol Synthesis Inhibition
PFAS inhibit CYP11B1, the enzyme converting deoxycortisol to cortisol in adrenal steroidogenesis. Suppressed cortisol production impairs stress response and immune modulation, predisposing exposed individuals to inadequate physiological stress adaptation.
HPA Axis Dysregulation
Beyond direct adrenal effects, PFAS alter glucocorticoid receptor sensitivity and hypothalamic CRH release patterns. These upstream HPA axis disruptions alter circadian cortisol rhythms, contributing to sleep disturbances, fatigue, and immune dysregulation in PFAS-exposed populations.
Clinical Endocrinology Considerations
Endocrinologists evaluating adrenal insufficiency or subclinical HPA axis dysfunction should assess PFAS exposures. Environmental exposure reduction may partially restore cortisol rhythm normalization in chemically burdened patients alongside standard adrenal support therapies.